HOOKIPA Pharma Inc.

12.09+0.0900+0.75%Vol 109.12K1Y Perf 51.00%
Apr 20th, 2021 16:00 DELAYED
BID12.03 ASK12.09
Open11.94 Previous Close12.00
Pre-Market- After-Market-
 - -  - -%
Target Price
20.50 
Analyst Rating
Strong Buy 1.00
Potential %
69.56 
Finscreener Ranking
★★★★+     56.72
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★★★     57.43
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★     52.05
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Market Cap313.98M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
58.37 
Earnings Date
13th May 2021

Today's Price Range

11.8812.18

52W Range

7.2815.52

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-4.28%
1 Month
-17.76%
3 Months
-0.98%
6 Months
24.77%
1 Year
51.00%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
HOOK12.090.09000.75
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.56-0.4617.86
Q03 2020-0.42-0.53-26.19
Q02 2020-0.46-0.2839.13
Q01 2020-0.39-0.43-10.26
Q04 2019-0.43-0.406.98
Q03 2019-0.66-0.4531.82
Q02 2019-0.47-0.63-34.04
Q01 2019-0.42-9.27-2 107.14
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.575.00Positive
6/2021 QR-0.57-3.64Negative
12/2021 FY-2.253.43Positive
12/2022 FY-2.255.06Positive
Next Report Date13th May 2021
Estimated EPS Next Report-0.57
Estimates Count3
EPS Growth Next 5 Years %4.80
Volume Overview
Volume109.12K
Shares Outstanding25.97M
Trades Count1.58K
Dollar Volume1.08M
Avg. Volume173.35K
Avg. Weekly Volume108.20K
Avg. Monthly Volume158.45K
Avg. Quarterly Volume185.02K

HOOKIPA Pharma Inc. (NASDAQ: HOOK) stock closed at 12.09 per share at the end of the most recent trading day (a 0.75% change compared to the prior day closing price) with a volume of 109.47K shares and market capitalization of 313.98M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 104 people. HOOKIPA Pharma Inc. CEO is Joern Aldag.

The one-year performance of HOOKIPA Pharma Inc. stock is 51%, while year-to-date (YTD) performance is 9.02%. HOOK stock has a five-year performance of %. Its 52-week range is between 7.28 and 15.52, which gives HOOK stock a 52-week price range ratio of 58.37%

HOOKIPA Pharma Inc. currently has a PE ratio of -7.40, a price-to-book (PB) ratio of 2.39, a price-to-sale (PS) ratio of 19.61, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -26.59%, a ROC of -34.82% and a ROE of -32.17%. The company’s profit margin is -%, its EBITDA margin is -217.40%, and its revenue ttm is $15.89 Million , which makes it $0.61 revenue per share.

Of the last four earnings reports from HOOKIPA Pharma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. HOOKIPA Pharma Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for HOOKIPA Pharma Inc. is Strong Buy (1), with a target price of $20.5, which is +69.56% compared to the current price. The earnings rating for HOOKIPA Pharma Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

HOOKIPA Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

HOOKIPA Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 6.63, ATR14 : 0.70, CCI20 : -146.22, Chaikin Money Flow : -0.15, MACD : 0.17, Money Flow Index : 38.00, ROC : -10.78, RSI : 33.37, STOCH (14,3) : 7.79, STOCH RSI : 0.00, UO : 38.00, Williams %R : -92.21), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of HOOKIPA Pharma Inc. in the last 12-months were: Igor Matushansky (Option Excercise at a value of $4 963), Igor Matushansky (Sold 28 359 shares of value $332 789 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.25
Strong Buy
1.25

HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

CEO: Joern Aldag

Telephone: +1 431 890-6360

Address: 350 Fifth Avenue, New York 10118, NY, US

Number of employees: 104

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

63%38%

Bearish Bullish

57%43%

News

Stocktwits